Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLN) Return on Invested Capital (2024 - 2025)

Historic Return on Invested Capital for Silence Therapeutics (SLN) over the last 2 years, with Q3 2025 value amounting to 0.99%.

  • Silence Therapeutics' Return on Invested Capital changed N/A to 0.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.99%, marking a year-over-year change of. This contributed to the annual value of 0.83% for FY2024, which is 17500.0% up from last year.
  • Latest data reveals that Silence Therapeutics reported Return on Invested Capital of 0.99% as of Q3 2025.
  • Silence Therapeutics' 5-year Return on Invested Capital high stood at 0.49% for Q4 2024, and its period low was 0.99% during Q3 2025.